BioCentury
ARTICLE | Company News

Labopharm, Angelini neurology, drug delivery news

July 4, 2011 7:00 AM UTC

Labopharm said its JV with Angelini, Angelini Labopharm, reduced its U.S. sales force for major depressive disorder (MDD) drug Oleptro trazodone by 65 (50%) to 65 to reduce costs. The reduction is ex...